By Chris Dolmetsch, Bloomberg News
A Long Island investment adviser and a lawyer he counseled were indicted for allegedly trading on inside information ahead of Pfizer Inc.’s $3.6 billion purchase of King Pharmaceuticals Inc. in 2010.
Tibor Klein, 43, of Melville, New York, the founder and president of Klein Financial Services, and Robert Schulman, 58, of McLean, Virginia, a former partner in a Richmond, Virginia-based law firm [Hunton & Williams], face as long as 20 years in prison if convicted. Prosecutors allege that Schulman learned of the pending acquisition through his representation of King and passed on the information when ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.